How many institutions held ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q4 2023?

28 institutional investors reported ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q4 2023. Use the holders table for investor-level position and value details.

Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)

Q: What does CUSIP 28617K101 represent in this 13F holders report?

CUSIP 28617K101 is the security identifier for ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 28617K101

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 78,762,953
Total 13F shares: 9,153,168
Share change: +235,446
Total reported value: $16,475,058
Price per share: $1.80
Number of holders: 28
Value change: +$507,102
Number of buys: 11
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP 28617K101?
CUSIP 28617K101 identifies ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 28617K101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BVF INC/IL	13F	Company	5.5%	4,326,710	$5,927,593	—	30 Sep 2023	13F
ARMISTICE CAPITAL, LLC	13F	Company	2.3%	1,824,000	$2,498,880	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	0.86%	674,520	$924,092	—	30 Sep 2023	13F
Woodline Partners LP	13F	Company	0.77%	603,993	$827,470	—	30 Sep 2023	13F
Gary A. Lyons	3/4/5	Director	— class O/S missing	150,437	$673,958	—	01 May 2023	3/4/5
Ensign Peak Advisors, Inc	13F	Company	0.56%	443,001	$606,911	—	30 Sep 2023	13F
CM Management, LLC	13F	Company	0.3%	234,803	$321,680	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	176,039	$241,258	—	30 Sep 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.2%	158,062	$217,000	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.08%	61,973	$85,000	—	30 Sep 2023	13F
JMAC ENTERPRISES LLC	13F	Company	0.07%	58,041	$79,516	—	30 Sep 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	56,576	$77,509	—	30 Sep 2023	13F
INGALLS & SNYDER LLC	13F	Company	0.07%	51,849	$71,000	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.06%	47,428	$64,976	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	0.06%	44,692	$61,228	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	0.04%	28,302	$38,774	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.03%	27,150	$37,196	—	30 Sep 2023	13F
MERCER GLOBAL ADVISORS INC /ADV	13F	Company	0.02%	16,726	$23,000	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	14,987	$20,532	—	30 Sep 2023	13F
SVB FINANCIAL GROUP	13F	Company	0.02%	13,472	$18,457	—	30 Sep 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	13,100	$17,947	—	30 Sep 2023	13F
PATHSTONE FAMILY OFFICE, LLC	13F	Company	0.02%	13,029	$17,850	—	30 Sep 2023	13F
Curi Capital, LLC	13F	Company	0.01%	10,000	$13,700	—	30 Sep 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	8,443	$11,567	—	30 Sep 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	4,850	$6,645	—	30 Sep 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0%	3,623	$4,000	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	0%	2,155	$2,952	—	30 Sep 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	172	$236	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	0%	26	$36	—	30 Sep 2023	13F
Walter C. Ogier	3/4/5	Director	— class O/S missing	150,437	—	—	01 May 2023	3/4/5

Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q4 2023

As of 31 Dec 2023, Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,153,168 shares. The largest 10 holders included BVF INC/IL, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Woodline Partners LP, Ensign Peak Advisors, Inc, GEODE CAPITAL MANAGEMENT, LLC, CM Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, and JMAC ENTERPRISES LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.